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Joanne Coyle2, Kate Jolly6, Jackie Miles7, Kevin Paul8, Patrick J. Doherty9, Russell Davies10, Hasnain Dalal11,12,
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Abstract
Background: Whilst almost 50% of heart failure (HF) patients have preserved ejection fraction (HFpEF), evidence-
based treatment options for this patient group remain limited. However, there is growing evidence of the potential
value of exercise-based cardiac rehabilitation. This study reports the process evaluation of the Rehabilitation
Enablement in Chronic Heart Failure (REACH-HF) intervention for HFpEF patients and their caregivers conducted as
part of the REACH-HFpEF pilot trial.
Methods: Process evaluation sub-study parallels to a single-centre (Tayside, Scotland) randomised controlled pilot
trial with qualitative assessment of both intervention fidelity delivery and HFpEF patients’ and caregivers’
experiences. The REACH-HF intervention consisted of self-help manual for patients and caregivers, facilitated over
12 weeks by trained healthcare professionals. Interviews were conducted following completion of intervention in a
purposeful sample of 15 HFpEF patients and seven caregivers.
Results: Qualitative information from the facilitator interactions and interviews identified three key themes for
patients and caregivers: (1) understanding their condition, (2) emotional consequences of HF, and (3) responses to
the REACH-HF intervention. Fidelity analysis found the interventions to be delivered adequately with scope for
improvement in caregiver engagement. The differing professional backgrounds of REACH-HF facilitators in this
study demonstrate the possibility of delivery of the intervention by healthcare staff with expertise in HF, cardiac
rehabilitation, or both.
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Conclusions: The REACH-HF home-based facilitated intervention for HFpEF appears to be a feasible and a well-
accepted model for the delivery of rehabilitation, with the potential to address key unmet needs of patients and
their caregivers who are often excluded from HF and current cardiac rehabilitation programmes. Results of this
study will inform a recently funded full multicentre randomised clinical trial.
Trial registration: ISRCTN78539530 (date of registration 7 July 2015).
Keywords: Cardiac rehabilitation, Heart failure, Preserved ejection fraction, Home-based, Process evaluation,
Caregivers
Key messages regarding feasibility
 What uncertainties existed regarding the feasibility?
People with heart failure with preserved ejection frac-
tion (HFpEF) have a high unmet need, experiencing low
levels of health-related quality of life and an absence of
evidence-based treatment options. Trials of clinical and
cost-effective therapies in the HFpEF population are
much needed. Rehabilitation Enablement in Chronic
Heart Failure (REACH-HF) is a healthcare professional-
facilitated home-based rehabilitation intervention de-
signed to improve self-care and health-related quality of
life in people with heart failure. Using qualitative re-
search methods, this pilot trial process evaluation sought
to address the uncertainties of (1) whether the REACH-
HF intervention could be delivered with acceptable fidel-
ity and (2) HFpEF patients’ and caregivers’ experiences
of participation in the intervention
 What are the key feasibility findings?
Results of this process evaluation sub-study of a
single-centre pilot trial showed the REACH-HF inter-
vention was largely successfully delivered and well re-
ceived by participants. However, whilst the fidelity
analysis found the interventions to be delivered ad-
equately over many of its components, we also found
scope for improvement—particularly in relation to care-
giver engagement.
 What are the implications of the feasibility findings
for the design of the main study?
This study highlights the need for support for HFpEF
patients and their caregivers. Results will guide the re-
search team in the design and delivery of a recently
funded multicentre trial of REACH-HF in this popula-
tion, i.e. (1) emphasis in the patient-facing documenta-
tion used for participant recruitment of the importance
of co-involvement of a caregiver (such as a spouse, fam-
ily member, or friend) to actively support the patient
with their engagement in the intervention; (2) enhance
the facilitator training of healthcare professions to high-
light both the challenges/opportunities of engaging care-
givers and the key role that caregivers can bring as
agents of sustainable patient behaviour change; and (3)
assess the fidelity of intervention delivery to check care-
giver engagement is achieved and to explore how fidelity
impacts on HFpEF patient and caregiver outcomes.
Background
In the United Kingdom (UK), approximately one million
people live with heart failure (HF)—a condition which
negatively affects cardiovascular functioning, often pre-
senting with debilitating symptoms of fatigue, shortness
of breath, reduced exercise capacity, and a potentially
dangerous accumulation of fluid in bodily tissues [1]. Al-
most 50% of HF patients have preserved ejection fraction
(HFpEF), and its prevalence is predicted to grow [1–3].
Although these patients are more often women, gener-
ally older, with a higher prevalence of co-morbidities
(hypertension, diabetes, and atrial fibrillation) and are
less likely to have coronary artery disease than those
with HF with reduced ejection fraction (HFrEF), their
prognosis, associated morbidity, mortality, health-related
quality of life (HRQoL), and healthcare costs are com-
parable [1–3].
The health burden of HFpEF on patients, caregivers,
the health system, and the broader economy is substan-
tial—with markedly reduced ability to perform activities
of daily living, poor health-related quality of life, and
high rates of unplanned hospitalisations and associated
healthcare costs, and premature mortality [4, 5]. In con-
trast to HFrEF, where drug and device therapies have
been demonstrated to improve life expectancy and
health-related quality of life, there is an absence of
evidence-based treatment options for individuals living
with HFpEF [6–9].
There is a growing body of evidence that exercise-
based cardiac rehabilitation (CR) can benefit people with
HFpEF [10]. CR is traditionally delivered in supervised
group hospital-based programmes. However, given the
current suboptimal uptake of CR, there is a need for al-
ternative models of CR delivery [11]. The Rehabilitation
Enablement in Chronic Heart Failure (REACH-HF) is a
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home-based rehabilitation intervention, facilitated by a
healthcare professional, and designed to improve self-
care and health-related quality of life in people with HF
and their caregivers and to improve their access to CR
[12].
The REACH-HFpEF pilot trial was a single-centre
study with the aim of assessing the feasibility of under-
taking a multicentre randomised trial to assess the clin-
ical effectiveness and cost-effectiveness of the REACH-
HF intervention in patients with HFpEF and their care-
givers [13]. The patient and caregiver outcome and cost
findings of the REACH-HFpEF pilot trial have been pre-
viously reported [14]. This paper presents the process
evaluation sub-study of the REACH-HFpEF pilot trial
that sought to assess the fidelity of intervention delivery
and patients’ and caregivers’ experiences of participation
in the REACH-HF intervention.
Methods
Design
Details of the REACH-HFpEF single-centre (Tayside,
Scotland) randomised pilot trial have been published
elsewhere [13, 14]. In brief, 25 HFpEF patients and 11
caregivers were allocated to either the REACH-HF inter-
vention plus usual care (intervention group) and 25 pa-
tients and 10 caregivers to usual care alone (control
group). Participating patients were aged 18 years or older
and had a diagnosis of HFpEF (i.e. left ventricular ejec-
tion fraction ≥ 45%) confirmed on echocardiography,
radionuclide ventriculography, or angiography within
the 6 months prior to study participation.
The process evaluation included a qualitative and
quantitative assessment of both the intervention fidelity
(i.e. the quality and consistency of the facilitators’ deliv-
ery of the REACH-HF intervention) and a qualitative ex-
ploration of both HFpEF patient and caregiver
experiences of the REACH-HF intervention, through
semi-structured interviews. The quantitative fidelity re-
sults have been previously reported [14]. Intervention
group participants were sampled for maximum variation
based on their age, gender, presence of a caregiver, and
psychological well-being (assessed by Hospital Anxiety
Depression Scale (HADS) [15]) to provide a purposive
sub-sample of 15 patients. Seven of these patients with
their caregivers agreed to participate in the qualitative
interviews. In accordance with the pilot trial protocol
[13], a sample of six patients and their caregivers were
selected to participate in the intervention fidelity
analysis.
REACH-HF intervention
The REACH-HF intervention is a comprehensive 12-
week practitioner-facilitated self-care support
programme co-designed with HF patients, caregivers,
and healthcare professionals [12]. It comprises (1) a pa-
tient ‘Heart Failure Manual’ that provides information
and interactive elements which target patients’ under-
standing of, and adaption to, living with HF, their medi-
cations, the rationale for engaging in exercise, and how
to monitor and manage HF-associated symptoms and
stress. The manual content was modified for this study
to reflect relevant medications, causes, and treatment of
HFpEF [13]; (2) a ‘Progress Tracker’ to record, review,
and monitor patient symptoms, well-being, physical ac-
tivity, and other self-management behaviours; (3) a
choice of an exercise training programme (chair-based
and/or walking); (4) information on managing stress and
anxiety (including an audio relaxation CD); and (5) a
‘Family and Friends Resource’ for caregivers that pro-
vides information to help them support patients and to
manage their own health and well-being.
REACH-HF participants were supported by one of two
nurse facilitators (one with experience in CR and the
other in HF) who had undergone a 3-day intervention
training course. Over the 12 weeks, there should typic-
ally be four to six contacts with the healthcare facilitator,
i.e. an initial 60–90min face-to-face consultation at the
patient’s home, up to three further ~ 30-min home
visits, and two to four telephone contacts. Facilitators
sought to increase the patient and caregiver understand-
ing of living with and self-managing their HF.
Data collection and analysis
Fidelity of intervention delivery
Facilitator interactions with participants were audio re-
corded, and the quality of delivery was assessed by an
experienced researcher/cardiac nurse (KS). A sub-
sample (three out of six patients) was independently
checked by a second experienced qualitative researcher
(JC). Scoring was discussed and compared to facilitate
consistency. Listening to the detailed facilitated interac-
tions provided additional rich data which would not
have been illuminated through patients and caregiver in-
terviews alone.
Semi-structured qualitative interviews
Fifteen patients, seven with caregivers, were interviewed
(by JC) after the completion of their intervention in par-
ticipant’s homes or by telephone, where a visit was not
possible, using a pre-defined topic guide (see e-
supplement). The interview assessed (1) participants’ un-
derstanding of their condition, (2) engagement with the
REACH-HF intervention in supporting their adjustment
to daily living with HFpEF, and (3) the perceived benefit
of the intervention, including self-care behaviours and
coping skills. Participants were encouraged by the re-
searcher and through further probing to openly express
their views. Interviews were audio-recorded and
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transcribed verbatim. Field notes were also completed (JC)
to enable reflection on the process, the interviewer’s per-
formance, and participants responses to questions and to
provide contextual information to the analysis, where rele-
vant. Reflexive memo notes were kept to assure the trans-
parency and trustworthiness of the analysis. Thematic
analysis [16] of the transcripts (led by JC and supported by
KS) included data familiarisation through repeated listen-
ing to the audio recordings and review of interview tran-
scripts. Initial codes, which summarised the content either
descriptively or interpretively, were created. Codes with
common features were then grouped together into emer-
gent themes, before finally being assigned to three inter-
pretive overarching themes. The themes are illustrated
using participant quotes. Independent analysis of a sample
of three transcripts by KS reflected the initial data codes,
provisional themes, and sub-themes suggested by JC. Dis-
cussion and interpretation of these findings allowed re-
finement of themes/subthemes through development of
definitions for each, as well as consideration and explor-
ation of additional perspectives and explanations. All par-
ticipants were asked if they wanted a copy of the interview
transcript to review and add comments; none requested
this. Both facilitators were also interviewed about their ex-
perience of delivering the intervention (by KS) using the
same process described above.
Quantitative data are summarised as mean and stand-
ard deviation (SD), unless stated otherwise.
Results
Study participants
The flow of study participants is shown in Fig. 1. Be-
tween April 2015 and June 2016, 50 patients were ran-
domised (intervention group, n = 25; control group, n =
25). The characteristics of the 15 patients and six care-
givers who participated in the process evaluation are
summarised in Table 1. Patients had a mean (± SD) age
of 71 (± 10.7) years with a similar proportion of men
and women. Caregivers were typically a spouse or part-
ner, younger (mean age 66 ± 10.6 years), and female.
The process evaluation sample was representative of the
trial intervention group [14].
Fidelity of intervention delivery
The six patients and caregivers included in the fidelity
analysis contributed a total of 41 facilitator interactions.
Of these, 34 were face-to-face contacts (mean duration
63min, range 10 to 154 min), and seven were telephone
contacts (mean duration 6 min, range 5 to 13 min). All
patient/caregiver and facilitator face-to-face contacts
were recorded with one exception due to audiotape mal-
function. In contrast, not all telephone interactions were
recorded and, in those which were, the recording quality
of the patient’s conversation was poor. The content of
the telephone interactions identified that they were often
used to briefly ‘check in’ with participants and confirm
their next scheduled face-to-face appointment, rather
than assess goal setting or discuss health issues.
The audio-recording analysis of the interactions
highlighted some excellent examples of the skilled facili-
tation using active listening skills. Facilitators listened
and responded to concerns, addressed health issues, cor-
rected misconceptions, and provided education, reassur-
ance, and support. They facilitated goal setting and
pacing within daily living and behaviour change by enab-
ling and empowering participants to better manage their
condition and engage in the REACH-HF intervention.
They also instilled confidence in patients and caregivers
through supportive interactions. In addition to many ex-
amples of excellent practice, this data also highlighted
areas for improvement, e.g. when important cues were
missed by facilitators, the absence of relatives in the in-
teractions, and lack of caregiver interaction (even when
the caregiver was physically present).
Semi-structured qualitative interviews
All 15 patients and seven caregivers completed the inter-
views with a mean duration of 42min (range 7 to 70min),
the majority undertaken either in participant’s homes (21)
or one by telephone. Three overarching themes and re-
lated subthemes emerged from the analyses: (1) under-
standing their condition, (2) emotional consequences of
HF, and (3) response to the intervention.
Theme 1: understanding their condition
Many participants were unaware of their HF diagnosis
and its potential severity. Participants often described a
protracted and uncertain path to diagnosis of their HF,
with symptoms being masked by other underlying condi-
tions and conflicting diagnostic information being pro-
vided by clinicians.
Reaction to diagnosis For a few participants, particu-
larly those who perceived themselves as ‘fit’ and healthy,
their HF diagnosis was a ‘shock’ which challenged their
current identity.
… I was shocked, I couldn’t believe it. I just couldn’t
believe, because I’ve always been very fit [Patient
interview 3]
Following diagnosis, others reported that they were
‘too frightened to do anything’. However, the majority
(13 patients) did not regard their HF as fatal and be-
lieved they could accommodate it in the way they had
with their other long-term conditions, seeing HF as a
continuation of a biography of adaptation to illness and
disability. For many patients, their diagnosis came as a
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relief because it normalised and explained their symptoms
(e.g. tiredness and breathlessness), making them less anx-
ious and enabling them to explain their symptoms and
condition to others. The majority felt the description of
HF in the REACH-HF manual, combined with the facilita-
tor’s explanation, aided their understanding of HF and
equipped them better to untangle, identify, and act on HF
symptoms. Some avoided reading or asking about HF, be-
lieving this was ‘morbid’ and a source of stress which
reminded them of the possibility of death.
Similar extremes in perspectives were reported by
caregivers with some viewing HF as ‘final’ (a ‘death sen-
tence’), requiring constant surveillance and the role of
caregiving was extremely stressful.
I think when you get diagnosed with heart failure,
from my point of view, the very word of heart
failure is absolutely terrifying...And the word ‘heart
failure’ is so completely final… you’re sort of…you’re
never relaxing. You’re always watching to see he’s
okay. You’re waking up in the middle of night, if
you’ve got to get up and you’re looking at him to
make sure he’s breathing… And then you think,
good, he’s just sleeping…if he’s not moving, you
think, why hasn’t he moved? [Caregiver Interview 20]
In contrast, others perceived that minor changes to
health behaviours, such as healthy eating and exercise, were
sufficient to maintain a good health-related quality of life.
Theme 2: emotional consequences of HFpEF
Loss of identity Some participants reported restricted
abilities and men especially struggled to adapt to these
Fig. 1 CONSORT diagram for REACH-HFpEF trial
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limitations expressing a strong sense of loss of identity.
For example, one participant repeatedly expressed:
I’m not the man I used to be. [Patient interview 7]
and another that:
Everything’s been taken away. [Patient Interview 13]
They often compared their lives now to those be-
fore their illness, e.g. related to their occupational
role or physical fitness. They were frustrated by how
others (e.g. family, health care staff) now perceived
them as individuals struggling with the constraints of
their condition. Some yearned for the opportunity to
demonstrate their more positive ‘former selves’, e.g.
confident people with a purpose in life. One partici-
pant even expressed it may be better for himself and
his family if he were dead:
I don’t want to be here, and everybody says: That’s
not fair to your wife or your kids. Wait a minute, I
say, Really? This is unfair to my wife and my kids.
My wife deserves to be taken away for the weekend.
I can’t do that. [Patient interview 13]
Caregivers confirmed this loss of social and profes-
sional roles in HF patients and acknowledged their per-
sonal challenges in managing such strong negative
emotion. Caregivers highlighted the importance of
regaining ‘a sense of purpose’.
… because I think he feels worthless. Sometimes I think
he wishes he wasn’t here. [Caregiver interview 13b]
Instead, when patients felt useful (e.g. helping other
people) or socialised and interacted with others, it lifted
them emotionally and motivated them to care for
themselves.
Recognising and responding to emotion Patients and
caregivers reported anger or low mood often related to
their feelings of frustration associated with the limitations
that HF imposed on their lifestyles. For six patients, the
manual helped them to recognise their altered mood.
Working with the facilitators enabled better management
of these emotions, sometimes drawing on existing strat-
egies, e.g. mindfulness or using new techniques, such as re-
laxation. Enabling patients to understand that these feelings
were ‘normal’ under the circumstances allowed caregivers
to support the patient’s psychological adjustment to their
HF. Caregivers suggested that the intervention had reduced
anxiety and improved mood, particularly in patients with
elevated HADS scores. As one caregiver described:
I just feel once he started to understand more about
heart failure, with the manual, that yes, he sort of -
I don’t know, sort of maybe accepted it more… I
think sometimes he sort of panics, thinking oh you
know, should I be feeling this way? Whereas having
the manual has, I think, sort of made him realise
yes, this is normal for me to feel like this and be like
this. [Caregiver Interview 18]
Caregivers also reported how the intervention posi-
tively addressed their own personal anxieties, thus allow-
ing them to be more supportive. As one spouse said:
someone like myself who needs the confidence to
know how to understand heart failure, to know how
be less anxious... because your stress goes on to the
patient … and can make them more anxious. So, if
you understand maybe a little bit more about it. …
you can sort of be more of a support. I think that’s
what I’m trying to say. [Caregiver Interview 20]
Theme 3: response to REACH-HF intervention
Engagement with the REACH-HF intervention While
all participants engaged with the intervention at some
level, this varied across the components. Participants
Table 1 Baseline characteristics of HFpEF patients and their
caregivers
HFpEF patients, n = 15 Caregivers, n = 6a
Gender (female), n (%) 9 (60) 5 (83)
Age (years), mean (SD) 70.4 (10.6) 62.8 (10.7)








HADS depression, n (%)
< 9 11 (73) 5 (83)
9–10 1 (7) 1 (17)
> 10 3 (20) 0 (0)
HADS anxiety, n (%)
< 9 9 (60) 2 (33)
9–10 2 (13) 2 (33)
> 10 4 (27) 2 (33)
Living alone, n (%) 5 (33)
aData was available for 6 of the 7 caregivers
SD standard deviation, HADS Hospital Anxiety and Depression Scale
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confirmed that the REACH-HF manual provided infor-
mation and reassurance: ‘offering something for every-
one’. In combination with the Progress Tracker, this
aided symptom monitoring and supported self-
management. Patients’ and caregivers’ accounts again re-
inforced their need to understand how to manage HF by
knowing what to look for in case of deterioration and
what to do in an emergency. Through improved under-
standing, caregivers felt more confident in supporting
the patients.
Most patients said that they followed the exercise rec-
ommendations within the manual and were able to pro-
gress satisfactorily through the chair-based exercise
programme (delivered by DVD) as advised by the facili-
tator, either alone or together with their caregiver. A few
patients needed guidance to prevent inappropriate rapid
progression through the exercise levels. Facilitators pro-
actively encouraged engagement in exercise, at times
completing the chair or walking programme with resist-
ant individuals. One participant, on the verge of giving
up, described how the facilitator had supported him to
identify and complete an alternative activity.
[She said] No, if you can’t do that what do you love
doing? I say, I love walking.
She went, Right, if you want to go out for a walk,
let’s go out for a walk.
[Patient Interview 13]
Such support provided participants with the know-
ledge and confidence to continue this themselves. Sev-
eral caregivers who completed the chair exercise or
walked with the patient valued this opportunity for so-
cial interaction and felt better emotionally afterwards.
Those with a positive perception of the exercises were
more strongly motivated to maintain them and integrate
this into their lives. The biggest barrier to exercise was
concurrent illness (e.g. chest pain) which either delayed
exercise initiation or progression and episodes of acute
illness (e.g. chest infection) which affected six partici-
pants and resulted in them stopping exercise for several
weeks then restarting at a reduced level. Of four patients
with co-ordination and balance problems, two adapted
by holding the back of chairs for balance and slowly pro-
gressing through the chair exercises. In contrast, the
other two patients discontinued their exercise
programme.
When progress through the exercise levels did not
match patients’ expectations, they were disappointed.
The facilitators played an extremely important role, en-
couraging them, affirming progress, and suggesting more
appropriate alternative exercise. Five other patients were
also disheartened, feeling the chair-based exercises had
not increased in intensity sufficiently nor challenged
them enough even at level seven. Caregivers confirmed
how the combined manual information and advice from
the facilitator increased their confidence to gauge and sup-
port more appropriate levels of exercise for the patient.
The negative impact of HF on participants’ normal
lifestyle and abilities could be profound as illustrated by
one man who loved gardening:
I had just a little bit of turf about that long and I
dug it up and whether it was the bending up or
down or just pushing the shovel in that made me
very unwell for I think it was about a week to
recover. That’s one of the things I’ve found now that
if I push myself and overdo it it’s the aftereffects
that last longer [Patient interview 7]
Again, facilitators helped patients to reframe their
thinking, set more realistic goals, and breakdown their
activities to make them manageable through goal setting
and pacing, which maintained a sense of achievement.
Changes in health-related behaviours The majority
(14 patients) reported some change in behaviour because
of the programme. Changes included maintaining the
exercise regime beyond completion of the programme
(13 patients), continued symptom tracking/monitoring
(eight patients), and dietary modifications (two patients).
Patients who perceived immediate symptomatic benefits
from the exercises were most likely to keep up their ex-
ercise regime. Others reported this had also improved
their sleep patterns. Most patients claimed they knew
about and followed healthy diets; two participants dis-
cussed the value of the healthy eating section. One de-
scribed how involvement in REACH-HF motivated him
to set new dietary goals which included healthier food
shopping and more home cooking. By setting goals and
applying pacing techniques, this enabled him to
complete his weekly shopping which had previously
been a challenge.
Only two participants continued to engage in undesir-
able health behaviours such as smoking and consuming
a high-fat diet. They did not causally connect these be-
haviours to their heart disease or weight gain.
Caregivers often described facilitators as the primary
motivation for behaviour change in patients, and the man-
ual was a useful resource to complement facilitator-
patient interactions. Caregivers typically encouraged and
supported patients to change their lifestyles, helping them
manage symptoms and engage in activities, reinforcing the
facilitator’s recommendations. Some also changed their
own behaviours. For example, one spouse reported:
[The facilitator] was very helpful for me in so many
different ways. Helping me to understand heart
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failure…she encouraged me to go out walking… Just
the reassurance that things were better, that there
was somebody there that was willing to, erm, say,
well, okay, you’re doing well. Even just the smallest
amount of encouragement. And ‘my husband always
felt better after [the facilitator] went away. Because
she felt…almost like a little security blanket, if you
want to say. That somebody was there, somebody
was asking. [Caregiver Interview 20]
Feeling that someone ‘cared’, listened, answered ques-
tions, and provided feedback and encouragement was
important to participants.
Monitoring and symptom tracking Use of the Progress
Tracker to record weekly symptom monitoring and ex-
ercise progress was variable. Some showed no desire to
complete this, expressing that
Filling it all in…. that is a bit annoying you know
what I mean [Patient Interview 1]
Others only completed specific sections, most com-
monly the weight and symptoms section. For those who
found the tracker helpful, this daily symptom assessment
was translated into long-term behaviour change extend-
ing beyond the REACH-HF intervention. Proactive
symptom monitoring also improved patients’ abilities to
communicate with doctors to allow prescribing of ap-
propriate treatment.
In contrast, a few participants disliked the repetitive-
ness of the tracker, even suggesting that this at times be-
came the focus of their interaction with the facilitator.
Every time she would come out she would start to
look back through the stuff but she would go right
to the front of the manual, not the manual the chart
you call it, and would go through preceding weeks
that she’d already covered [Patient Interview 7]
Nearly all caregivers believed that monitoring and
assessing the physical and mental health of the patient
was the most important but also a very difficult aspect
of their role. Identifying signs and symptoms, deciding
on their seriousness, and whether they related to HF or
another condition then initiating appropriate action was
challenging. As one spouse described:
I suppose his breathing and I know like he’s been
quite concerned about sort of circulation in his legs.
I don’t even know if that’s connected to the heart
failure or if that’s something else, because he has
got quite a few health problems. [Caregiver
Interview 18]
Proximity to the patients and frequency of contact also
influenced caregivers’ perceptions of their engagement
in REACH-HF. One caregiver despite living over 50
miles away provided an excellent example of monitoring
her relative’s physical and emotional state and adopting
a ‘virtual caregivers role’ providing encouragement and
emotional support through mobile technology using
texts or more often FaceTime. She described the benefit
of how
you can see it on him, to be honest. Sometimes he
doesn’t look too good… his breathing isn’t good and
he looks kind of grey… I suppose FaceTime is a dif-
ferent way of doing things and…. It’s lets you be in-
volved. [Caregiver Interview 18]
Although using technology allowed her to assess his
appearance, body language, and suggest interventions in
a similar way to face-to-face caregivers, what differed
was her limited ability to provide physical assistance.
The patient could also choose not to converse over vis-
ual media (especially if they are feeling particularly un-
well). This obviously undermines the virtual caregiver’s
ability to assess the situation and can cause them stress,
worry, and sleepless nights.
Unique caregiver views and experiences Within this
study, there was a strong reluctance to be identified as
‘caregivers’, even when the ‘caregiver’ assisted the patient
in activities such as washing and dressing. Caregivers
regarded their caring role as ‘fluid’. Most described pro-
viding minimal physical assistance on a day-to-day basis
with increased help when away from home or during ep-
isodes of patient’s illness. Caregivers also highlighted
how balancing competing demands on their time (e.g.
caring roles for other family members), or their own
health status, could affect the support they were able to
give. Despite these challenges, caregivers did report ex-
amples of acting as an enabler and motivator, especially
in encouraging patients to exercise, often by doing this
together.
Use of the friends and family resource also varied. Some
read this from cover to cover, then used it as a reference
(to review the meaning of symptoms or reinforce the facil-
itator’s advice by referring the patient to that section of
the manual) and a guide to action. However, the majority
were intermittent engagers, often reading the information
explaining HF or quickly glancing through it. Caregivers
with no or intermittent engagement believed that the
manual was primarily for the patient.
Discussion
This process evaluation study has benefited from a
qualitative approach which enabled greater
Smith et al. Pilot and Feasibility Studies            (2021) 7:11 Page 8 of 11
understanding of the issues surrounding HFpEF and the
application of REACH-HF intervention. Through mul-
tiple data sources, we observed that the intervention was
largely successfully delivered and well received by partic-
ipants. This study also highlights the genuine need for
support in a population often excluded from many exist-
ing HF and CR services [6]. The home-based nature of
the REACH-HF intervention also offers an opportunity
to overcome the current challenge of suboptimal uptake
of CR [1, 11].
Whilst our previously reported quantitative fidelity
analysis found the REACH-HF intervention was ad-
equately delivered by facilitators over most of its compo-
nents, we also found there was scope for improvement
[14]. This was particularly the case in relation to engage-
ment with caregivers, a finding also reported with HFrEF
patients [17]. Unique insights from the analysis of audio
recordings of facilitator interactions provided rich data
extending beyond the confines of the previously reported
fidelity scores, exemplifying good practice and identify-
ing potential areas for improvement in consultation
skills. Facilitators also captured written notes of their
consultations as part of a self-assessment. Complement-
ing these with reflection on the recordings of consult-
ation offered a powerful tool to enable self-reflection
and professional development for practitioners. Care-
givers believed that REACH-HF was for the patient and
not for them, suggesting a more proactive strategy for
caregiver involvement may be required in future inter-
vention delivery [17].
The need to understand and know how to manage
their HF reinforces earlier research in HFrEF patients
[18, 19] and caregivers [20, 21]. Addressing participants’
needs for clarity in relation to their diagnosis and the
implications of this condition can increase understand-
ing, alleviate patient and caregivers’ anxiety, and allow
them to accept and accommodate HF in their lives.
Greater knowledge and confidence in caregivers can also
enable more appropriate patient monitoring and sup-
port, confirming previously reported findings of opti-
mised symptom management and self-care behaviour
[21, 22]. Some participants valued monitoring as a meas-
ure of their progress and stability, others seeing this as a
chore which has also been reported in the use of symp-
tom monitoring diaries [23].
Increasing patient’s and caregiver’s knowledge of HF is
a core element in HF care provision [24, 25]. For ex-
ample, enabling them to link symptoms (e.g., breathless-
ness and increased body weight) allows earlier detection
and prevention of HF-related deterioration. This was
achieved through information provided in the manual
and explanations by facilitators. The importance of feel-
ing that someone listened and cared, acknowledged
emotions, illness beliefs, anxiety, and depression, yet
provided feedback and encouragement to improve self-
efficacy, was all highlighted by the participants. These
are critical issues in empowering patients to self-monitor
and optimise their health-related quality of life [26]. Ap-
plying goal setting and pacing techniques to break down
tasks (e.g. shopping, housework, and gardening) into
manageable elements also allowed more proactive self-
management of their condition.
The analysis from the current study suggests that
HFpEF patients and their caregivers have a number of
unmet needs and that the REACH-HF intervention may
offer a possible solution to address this gap. The role of
facilitators in implementing the REACH-HF programme
is crucial. The facilitator had an important role in the
prescription and support of exercise and other lifestyle
change during the programme and enabled many partic-
ipants to maintain exercise and dietary changes beyond
completion of the programme, reflecting previous work
[20]. Caregivers were often better able to recall and de-
scribe the interactions between the facilitator and the
patient or themselves than the content of the REACH-
HF manual. By employing counselling and coaching
skills, listening to patients’ concerns, providing reassur-
ance, reframing problems, helping them to adapt to any
limitations, and motivating the patient (and the care-
givers) to take exercise, the facilitator assisted both pa-
tients and caregivers in their caring role.
Strengths and limitations
This study has a number of strengths. First, it benefited
from a qualitative method approach which enabled
greater understanding of the issues surrounding HFpEF.
Second, REACH-HF is a home-based rehabilitation
intervention for HFpEF patients (and their caregivers), a
high need population with limited access to HF and re-
habilitation services. Third, we successfully recruited the
target number of HFpEF patients for semi-structured in-
terviews, strengthened by including their respective care-
givers, who are often excluded in HF research studies
[27]. Fourth, we assessed adherence to intervention pro-
tocols and the quality of consultation interactions and
explored HFpEF patients’ and caregivers’ experiences of
this. Fifth, qualitative data also captured some examples
of good practice in education, engagement, and support
of HFpEF patients and their caregivers. Sixth, complet-
ing fidelity analysis may be a useful tool for self-
reflection and improving professional practice for spe-
cialist nurses. Finally, we believe this process evaluation
enhanced the reliability of the outcome results and are
in keeping with the findings of the process evaluation
conducted alongside our multicentre randomised con-
trolled trial in patients with HFrEF [17]. Our learning
from this study will inform future optimisation of the in-
terventions for HFpEF [28, 29] and a full trial in a
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number of ways: (1) patient-facing documentation used
for participant recruitment emphasising the importance of
co-involvement of a caregiver (such as a spouse, family
member, or friend) to actively support the patient with
their engagement in the intervention; (2) enhance the
training of healthcare professions facilitating the interven-
tion and highlight both the challenges and opportunities
of engaging caregivers and the key role that caregivers can
bring as agents of sustainable patient behaviour change;
and (3) assess the fidelity of intervention delivery to check
if full caregiver engagement is achieved and to explore
how it impacts on HFpEF patient and caregiver outcomes.
However, this study also had limitations. Our translation
of complex interpersonal interactions into numerical scores
within the fidelity analysis was unable to fully illustrate
some of the excellent examples of good practice. Facilita-
tors often demonstrated high levels of skill and competence
in providing tailored educational and psychological support,
enabling patients to reframe negative thoughts, engage in
appropriate exercise, and participate in self-management.
The sample size within this study was small, and the char-
acteristics of the participants (predominantly of white eth-
nic origin) from a single centre limit the potential
generalisability and may have failed to achieve theoretical
saturation/information redundancy. Whilst the assessment
of the fidelity of interventions by independent researchers
enhanced confidence in the results, their varied professional
backgrounds (nurse researcher and social scientist) may
have influenced interpretations of the fidelity scoring.
Conclusions
This process evaluation provides important evidence sup-
porting the feasibility and acceptability of delivering the
REACH-HF intervention that has the potential to address
some key unmet needs in HFpEF patients and their care-
givers. One of the most important intervention components
identified by this study was the role of the healthcare facili-
tator, who acted as an educator, a source of support and re-
assurance, as well as a motivator and enabler. The
facilitators helped to reframe participants’ thoughts to en-
able engagement in activity, symptom monitoring, and self-
management of their HF through realistic goal setting and
pacing. The study also identified how involving caregivers
was at times challenging, and a more proactive strategy
may be required to optimise this part of the intervention in
future applications and clinical trials. The findings of this
process evaluation will inform a future multicentre trial.
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